Trials / Completed
CompletedNCT02749487
Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients
Neutrophil Lymphocyte and Platelet Lymphocyte Ratios as Predictors of Outcome in Traumatic Critically Ill Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Neutrophil lymphocyte ratio NLR is an important index that evaluate the inflammatory status . It is a cost effective and readily available , and simply calculated , so that why investigators try to use it as a predictor of short term survival in the critically ill patients
Detailed description
NLR will be used as predictor for short term survival and patients stay in ICU in 2 groups of patients . Investigators will use it in a group of Medical Critically ill patients as respiratory failure , neuromuscular disorders , renal impairment . the other group is the critically ill surgical patients , as patients with multiple trauma , post major surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neutrophil Lymphocyte Ratio | Neutrophil:lymphocyte ratio (NLR) is an emerging biomarker that is used to predict mortality and morbidity. The association of this biomarker with systemic illness and its usefulness in risk assessment of critically ill patients has not been fully elucidated. |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2016-05-01
- Completion
- 2016-09-01
- First posted
- 2016-04-25
- Last updated
- 2016-12-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02749487. Inclusion in this directory is not an endorsement.